Pediatric Organ Transplantation in China

Area of Science:

• Pediatric Transplantation
• Organ Donation and Transplantation Policy
• Healthcare System Development

Background:

• China's healthcare system serves over 1.4 billion people.
• Organ transplantation, including pediatric cases, has seen significant advancements.
• The period reviewed is 2015-2024, following major reforms.

Purpose of the Study:

• To provide a comprehensive overview of pediatric organ transplantation in China.
• To summarize national trends, regulatory frameworks, clinical outcomes, and challenges.
• To analyze the impact of policy reforms on pediatric transplantation.

Main Methods:

• Data sourced from the Report on Organ Donation and Transplantation in China (RODTC).
• Analysis of pediatric patients (under 18) undergoing kidney, liver, lung, and heart transplants.
• Review of regulatory frameworks, allocation policies (COTRS), and survival rates.

Main Results:

• Significant increases in pediatric kidney (4.9x), liver (2.1x), lung (7.5x), and heart (2.5x) transplants from 2015-2024.
• Favorable 5-year patient survival rates: 70.0% for heart, 95.5% for kidney.
• Leading indications include cardiomyopathy, bronchiolitis obliterans, biliary atresia, and glomerulonephritis.

Conclusions:

• Pediatric organ transplantation in China has advanced rapidly due to ethical oversight and child-priority allocation reforms.
• Challenges persist, including data accessibility, regional disparities, and donor shortages.
• Continued policy refinement, registry expansion, and regional collaboration are crucial for improving outcomes.